We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cytokine Activity Links Resistin to Obesity and Diabetes

By Biotechdaily staff writers
Posted on 15 Dec 2004
Researchers seeking to establish a link between obesity and diabetes have found that levels of resistin, a hormone produced by fat cells in mice and by immune macrophages in humans, are chronically elevated in obese individuals.

Resistin, a small protein (114 amino acids) secreted by fat cells in mice, causes tissues-- especially the liver--to be less sensitive to the action of insulin, which is the hallmark of noninsulin-dependent diabetes mellitus (NIDDM), known as type 2 diabetes. Blood glucose levels rise because of increased glycogenolysis and gluconeogenesis in the liver. In humans, resistin is primarily a product of macrophages, not fat cells. Nevertheless, there is a strong association in humans between elevated levels of resistin, obesity, and type 2 diabetes. More than 80% of individuals with NIDDM are obese.

Investigators at the University of Pennsylvania School of Medicine (Philadelphia, USA), who had been the first to identify resistin in mice, worked with obese humans and human macrophage cultures to establish the role of the hormone in humans. They reported in the November 30, 2004, issue of PloS Biology that inflammatory stimulators such as bacterial endotoxin significantly increase resistin production in macrophages and serum levels in patients. This response could be blocked by the rosiglitazone and by aspirin, two drugs that have dual anti-inflammatory and insulin-sensitizing actions. Cytokines were required for the increase in resistin in the presence of endotoxin.

"That told us that cytokines like TNF-alpha and IL-6 are responsible for the increase in resistin in macrophages,” explained senior author Dr. Mitch Lazar, chief of the division of endocrinology, diabetes, and metabolism at the University of Pennsylvania School of Medicine. "Our work suggests that the increases in resistin seen in people is related to the increase in cytokines. The hypothesis is that there is cross-talk between fat cells and macrophages via cytokines, both in mice and humans.”





Related Links:
University of Pennsylvania School of Medicine

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
All-in-One Molecular System
AIO M160
New
Automated Clinical Chemistry Analyzer
Envoy 500+

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
15 Dec 2004  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
15 Dec 2004  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
15 Dec 2004  |   BioResearch